Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator.
- 1 January 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Vol. 9 (1) , 43-49
- https://doi.org/10.1161/01.atv.9.1.43
Abstract
Fibrin formed on endothelial cells has previously been shown to have deleterious effects on the cells. Additionally, substances that cause endothelial cell damage have been reported to induce cultured endothelial cells to synthesize prostacyclin and tissue plasminogen activator (t-PA). The present studies were undertaken to determine whether fibrin formed on cultured human umbilical vein endothelial cells would alter synthesis of prostacyclin and t-PA by the cells. Fibrin was found to increase synthesis of both prostacyclin and t-PA in a dose and time dependent manner. Stimulation of prostacyclin synthesis was completely inhibited by indomethacin; partially inhibited by actinomycin D, cycloheximide, and trifluoperazine; and not affected by cytochalasin D or vinblastine. In contrast, stimulation of t-PA synthesis was completely inhibited by actinomycin D and cycloheximide; partially inhibited by cytochalasin D, vinblastine, and trifluoperazine; and not affected by indomethacin. Fibrin I, formed with Reptilase, caused only slight stimulation of t-PA production, but virtually no stimulation of prostacyclin synthesis. Neither collagen polymerization on the cells nor thrombin added in concentrations that did not induce fibrin polymer formation stimulated production of either substance. Furthermore, soluble fibrin II generated in the presence of the fibrin polymerization inhibitor gly-pro-arg-pro also failed to stimulate either prostacyclin or t-PA production. The presence of platelets in the plasma from which the fibrin was formed did not affect the amount of stimulation of the cells. Fibrin-induced stimulation of endothelial cell production of prostacyclin and t-PA could act to limit vascular occlusion in vivo by inhibiting platelet function and by stimulating fibrinolysis via t-PA.This publication has 28 references indexed in Scilit:
- Binding of tissue plasminogen activator to cultured human endothelial cells.Journal of Clinical Investigation, 1987
- Fibrinogen induces adhesion, spreading, and microfilament organization of human endothelial cells in vitro.The Journal of cell biology, 1987
- Fibrin induces release of von Willebrand factor from endothelial cells.Journal of Clinical Investigation, 1987
- Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells.Journal of Clinical Investigation, 1984
- Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial CultivationScience, 1983
- Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cellsAtherosclerosis, 1983
- Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in cultureAtherosclerosis, 1982
- Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation.Journal of Clinical Investigation, 1981
- Damage of cellular functions by trifluoperazine, a calmodulin-specific drugExperimental Cell Research, 1980
- Selective Inhibition in Human Pregnancy Blood of Urokinase Induced EibrinolysisScandinavian Journal of Clinical and Laboratory Investigation, 1963